The University of Southampton
University of Southampton Institutional Repository

Addressing multiple neurodivergent identities in clinical and research settings

Addressing multiple neurodivergent identities in clinical and research settings
Addressing multiple neurodivergent identities in clinical and research settings
Neurodiversity is a concept that embraces the different ways that the human brain processes information, functions, and presents behaviourally.1 Instead of thinking in terms of a medical disability that requires treatment, neurodiversity allows the reframing of different brain–behaviour patterns as a form of diversity. Among neurodivergent identities, attention-deficit hyperactivity disorder (ADHD) has a pooled worldwide estimated prevalence of up to 7%, followed by autism at 3–4%.2 Neurodivergent identities are rarely singular, for example 37–85% of autistic children also have ADHD symptoms.3 Despite such high co-occurrence, and the consequential need to reframe the understanding of neurodevelopmental differences as likely to be plural, clinical awareness of them as co-occurring conditions is less established. Part of the lack of awareness comes from the evolution in diagnostic and clinical guidelines, which has happened only in the past 10 years, regarding the identification and therapeutic support of, for example, ADHD and autism as potentially simultaneous conditions.4 Co-occurrence of autism and ADHD was not formally recognised until the fifth revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), published in 2013. This previous lack of recognition of the possibility of multiple neurodivergence led to uncertainty among health-care practitioners when working with autistic and ADHD children, adolescents, and adults.4 Consequently, screening for multiple neurodivergent conditions is not yet standard clinical practice worldwide. This lack of screening results in late for developmental age diagnoses for simultaneously occurring conditions, such as autism and ADHD; single diagnoses overshadowing a second condition, despite the presentation of multiple neurodivergent conditions; and delayed psychiatric referral, as there is little clinical consensus on how to and who should identify and support multiple-neurodivergent people.
2352-4650
5-6
Chellappa, Sarah
516582b5-3cba-4644-86c9-14c91a4510f2
Chellappa, Sarah
516582b5-3cba-4644-86c9-14c91a4510f2

Chellappa, Sarah (2025) Addressing multiple neurodivergent identities in clinical and research settings. The Lancet Child & Adolescent Health, 9 (1), 5-6. (doi:10.1016/s2352-4642(24)00261-x).

Record type: Article

Abstract

Neurodiversity is a concept that embraces the different ways that the human brain processes information, functions, and presents behaviourally.1 Instead of thinking in terms of a medical disability that requires treatment, neurodiversity allows the reframing of different brain–behaviour patterns as a form of diversity. Among neurodivergent identities, attention-deficit hyperactivity disorder (ADHD) has a pooled worldwide estimated prevalence of up to 7%, followed by autism at 3–4%.2 Neurodivergent identities are rarely singular, for example 37–85% of autistic children also have ADHD symptoms.3 Despite such high co-occurrence, and the consequential need to reframe the understanding of neurodevelopmental differences as likely to be plural, clinical awareness of them as co-occurring conditions is less established. Part of the lack of awareness comes from the evolution in diagnostic and clinical guidelines, which has happened only in the past 10 years, regarding the identification and therapeutic support of, for example, ADHD and autism as potentially simultaneous conditions.4 Co-occurrence of autism and ADHD was not formally recognised until the fifth revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), published in 2013. This previous lack of recognition of the possibility of multiple neurodivergence led to uncertainty among health-care practitioners when working with autistic and ADHD children, adolescents, and adults.4 Consequently, screening for multiple neurodivergent conditions is not yet standard clinical practice worldwide. This lack of screening results in late for developmental age diagnoses for simultaneously occurring conditions, such as autism and ADHD; single diagnoses overshadowing a second condition, despite the presentation of multiple neurodivergent conditions; and delayed psychiatric referral, as there is little clinical consensus on how to and who should identify and support multiple-neurodivergent people.

This record has no associated files available for download.

More information

e-pub ahead of print date: 18 November 2024
Published date: 9 January 2025

Identifiers

Local EPrints ID: 502832
URI: https://eprints.soton.ac.uk/id/eprint/502832
ISSN: 2352-4650
PURE UUID: 2b03d758-854f-4356-99bc-e9738ec54efa
ORCID for Sarah Chellappa: ORCID iD orcid.org/0000-0002-6190-464X

Catalogue record

Date deposited: 09 Jul 2025 16:32
Last modified: 03 Oct 2026 02:40

Export record

Altmetrics

Contributors

Author: Sarah Chellappa ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of https://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×